Biotech outlook for 2026

Kaveri explains macro tailwinds: M&A, patent cliffs, lower rates, strategic areas like INI, oncology, neurology.

Play episode from 00:23

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!